Canopy Growth (TSX:WEED) Tanks Again: How Low Could the Stock Go?

Canopy Growth just reported weak quarterly results. What’s next for this cannabis stock?

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

Canopy Growth (TSX:WEED)(NASDAQ:CGC) is down 17% for the day at the time of writing, hitting a new multi-year low under $6 per share. Investors who stayed on the sidelines during the rout over the past 15 months are wondering if Canopy Growth stock is finally oversold and undervalued.

Canopy Growth results

Canopy Growth reported weak results for its latest quarter. The business saw net revenue drop 25% to $111.8 million from $148.4 million in the same period last year. The big hit came as global cannabis sales plunged from $101.3 million to just $66 million. Canopy Growth’s other consumer products sales, including the drinks business, generated more stable results with revenue coming in at $45.8 million compared to $47.1 million in the same three months last year.

Canopy Growth reported a net loss of $575 million, or $1.46 per share, for the latest quarter. The net loss in the same period in the previous year was worse at $700 million.

Management is still optimistic on the business with a goal of reaching profitability in 2024. The company is trimming costs and focusing on key strategic markets. Canopy Growth cut 250 jobs in a recent downsizing and has reduced its retail footprint by closing stores and exiting some international markets.


The entire cannabis industry is hoping the U.S. will eventually legalize the sale of cannabis products at the federal level. So far, only a handful of states allow the sale of cannabis products.

Over the past couple of years, the sector has rallied on hints that the move is on the way, but the reality is that it could still be quite a while. However, assuming cannabis will eventually be legalized in the U.S. at the federal level, Canopy Growth is positioned well to capitalize. The company, through strategic acquisitions, has established the scale and reach to quickly take advantage of the opening of the American market.

At home, cannabis-infused drinks have not taken off as expected in Canada. That could change in 2022 and 2023 as the end of pandemic restrictions brings the return of festivals, where Canopy Growth and its peers can showcase the products.


The black market continues to be a formidable competitor in Canada for legal cannabis products. Canopy Growth has also had to change its product offerings to accommodate shifts in consumer preferences. In what is essentially a commodity market, making money could prove to be difficult in the next few years.

Should you buy Canopy Growth stock now?

The trend isn’t an investor’s friend today and many people have been burned trying to catch this falling knife. Investors might be able to pick up a quick gain on a rebound, but I would keep any speculative bets small at this point.

The turnaround process is going to take time and the next quarterly results might not show much of an improvement.

Canopy Growth’s major shareholder, Constellation Brands, appears committed to seeing the business succeed. That’s positive for shareholders and the financial support from the drinks giant should ensure Canopy Growth survives. The risk for investors, however, is that Constellation Brands might decide to take Canopy Growth private. Depending on the price it pays, investors hoping for a rebound to recoup losses might get burned.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends Constellation Brands. Fool contributor Andrew Walker has no position in any stock mentioned.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »

A cannabis plant grows.
Cannabis Stocks

Can Aurora Cannabis Stock Recover in 2024?

Aurora Cannabis stock is down 99% from all-time highs but remains a high-risk bet, despite its cheap valuation.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

The Best Cannabis Stock to Buy Right Now

This cannabis stock has jumped 30% in the last few months, with even more growth on the way – all…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Down 99% From All-Time Highs, Is Canopy Growth Stock a Good Buy Right Now?

Canopy Growth stock is a high-risk investment due to its negative profit margins and challenging liquidity position.

Read more »

Marijuana plant and cannabis oil bottles isolated
Stocks for Beginners

Aurora Cannabis’ Reverse Stock Split: Is the Stock a Buy Today?

Cannabis stock Aurora (TSX:ACB) is consolidating shares once again, but what does this mean for investors?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Where Will Cannabis Stocks Be in 10 Years?

Cannabis stocks could see a huge shift upwards should marijuana be rescheduled in the U.S., but you can still buy…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Forget Canopy Growth: 1 Cannabis Stock With Far Less Risk

Cannabis stocks like Canopy Growth (TSX:WEED) haven't done well for quite some time, yet this one deserves a major boost!

Read more »